HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dulloo, A. G Articles by Vandermander, J. Search for Related Content PubMed PubMed Citation Articles by Dulloo, A. G Articles by Vandermander, J. Agricola Articles by Dulloo, A. G Articles by Vandermander, J.

Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans^1,2,3

¹ From the Department of Physiology, Faculty of Medicine, University of Geneva; Geneva University Hospital; and Laboratoires Arkopharma, Nice, France.

² Supported in part by Arkopharma Laboratories and by the Swiss National Science Research Fund.

³ Address reprint requests to AG Dulloo, Institute of Physiology, University of Fribourg, Rue de Musée 5, CH-1700 Fribourg, Switzerland. E-mail: abdul.dulloo{at}.unifr.ch.

	ABSTRACT

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Background: Current interest in the role of functional foods in weight control has focused on plant ingredients capable of interfering with the sympathoadrenal system.

Objective: We investigated whether a green tea extract, by virtue of its high content of caffeine and catechin polyphenols, could increase 24-h energy expenditure (EE) and fat oxidation in humans.

Design: Twenty-four–hour EE, the respiratory quotient (RQ), and the urinary excretion of nitrogen and catecholamines were measured in a respiratory chamber in 10 healthy men. On 3 separate occasions, subjects were randomly assigned among 3 treatments: green tea extract (50 mg caffeine and 90 mg epigallocatechin gallate), caffeine (50 mg), and placebo, which they ingested at breakfast, lunch, and dinner.

Results: Relative to placebo, treatment with the green tea extract resulted in a significant increase in 24-h EE (4%; P < 0.01) and a significant decrease in 24-h RQ (from 0.88 to 0.85; P < 0.001) without any change in urinary nitrogen. Twenty-four–hour urinary norepinephrine excretion was higher during treatment with the green tea extract than with the placebo (40%, P < 0.05). Treatment with caffeine in amounts equivalent to those found in the green tea extract had no effect on EE and RQ nor on urinary nitrogen or catecholamines.

Conclusions: Green tea has thermogenic properties and promotes fat oxidation beyond that explained by its caffeine content per se. The green tea extract may play a role in the control of body composition via sympathetic activation of thermogenesis, fat oxidation, or both.

Key Words: Obesity • thermogenesis • catechins • polyphenols • caffeine • sympathetic nervous system • green tea • fat oxidation • catecholamines • men

	INTRODUCTION

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Fundamentally, there are only 2 ways to treat obesity: reduce energy intake or increase energy expenditure (EE). Because thermogenesis and fat oxidation are to a large extent under the control of the sympathetic nervous system (SNS), approaches that mimic or interfere with the SNS and its neurotransmitter norepinephrine offer a rational approach for obesity management (1–3). In this context, there has been renewed interest in the potential thermogenic effects of many compounds extracted from plants (eg, caffeine from coffee and tea, ephedrine from ephedra, and capsaicin from pungent spices), largely because of their potential to modulate catecholamine release and activity (4) . For example, capsaicin-rich foods (eg, chili peppers and red peppers) have been shown to stimulate fat oxidation and thermogenesis in humans (5, 6), and caffeine in relatively small amounts can potentiate thermogenesis induced by sympathetic stimuli, whether in response to cold, moderate exercise, or sympathomimetic drugs like ephedrine (7). In fact, long-term clinical trials have shown greater losses in body weight and body fat in obese patients treated with a combination of caffeine and ephedrine than in those treated with placebo, caffeine, or ephedrine alone (8).

Previous work in our laboratory, in which an in vitro system was used to measure the respiration rate of brown adipose tissue in rats, suggests that the interaction between caffeine and ephedrine resides in ephedrine's induced enhancement of sympathetic neural release of norepinephrine together with caffeine's ability to inhibit the phosphodiesterase-induced degradation of intracellular cyclic AMP (cAMP), and, to a lesser extent, caffeine's antagonism of the negative modulatory effect of adenosine on increased norepinephrine release (9). The net result, therefore, would be an elevated cellular concentration of cAMP—a critical intracellular mediator for the actions of catecholamines on thermogenesis. Apart from phosphodiesterases, adenosine, and certain prostaglandins, the concentration of norepinephrine at the synaptic junction and its interaction with adrenoceptors is also likely to be negatively modulated through its enzymatic degradation, namely by catechol O-methyltransferase (COMT) (10). Given evidence that this enzyme can be inhibited by certain tea polyphenols (11), we recently investigated in our in vitro system whether an extract of green tea, by virtue of its high content of both caffeine and catechin polyphenols, could be an effective promoter of thermogenesis. These in vitro results (12) can be summarized as follows: 1) the green tea extract was found to be more effective than were equivalent amounts of caffeine in stimulating peripheral tissue thermogenesis, and 2) this difference between the green tea extract and equimolar caffeine in activating thermogenesis was much more marked under conditions of increased norepinephrine release because the synergistic interaction between the green tea extract and ephedrine on tissue thermogenesis was much more pronounced than that of caffeine or ephedrine.

On the basis of these in vitro data, our main objectives in this study were 2-fold: 1) to examine the extent to which daily administration of capsules containing a green tea extract (containing catechin polyphenols and caffeine in amounts comparable with those commonly consumed in green tea beverages in Asian communities) would stimulate thermogenesis and increase daily EE in humans, and 2) to determine whether the effects of the green tea extract on the metabolic rate and substrate oxidation in humans would be greater than that explained by its caffeine content per se.

	SUBJECTS AND METHODS

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Subjects
Healthy young men were recruited from the student and staff population of our University after complete medical and nutritional histories were obtained by use of a questionnaire. Smokers, competitive athletes, and persons who engaged in intense physical activities or who had a history of weight loss were not eligible for inclusion in the study. Inclusion criteria included body fatnesses ranging from lean to mildly obese (8-30% body fat). All selected subjects habitually consumed a typical Western diet, with fat contributing 35–40% of dietary energy intake, and their estimated intake of methylxanthines (mostly as caffeine-containing beverages) ranged from 100 to 200 mg/d. At the onset of the study, body weight and height were measured and body fat was determined by the method of Durnin and Womersley (13) from measurements of skinfold thicknesses taken at 4 sites with a Harpenden skinfold caliper (British Indicators, Ltd, London); fat-free-mass (FFM) was calculated as the difference between body weight and body fat. Mean (±SEM) values for some of the physical characteristics of the 10 men participating in this study were as follows: age, 25 ± 1 y; height, 177 ± 3 cm; weight, 78.7 ± 4.3 kg; body mass index (BMI; in kg/m²), 25.1 ± 1.2; percentage body fat, 18.2 ± 1.8%; and FFM, 63.8 ± 2.5 kg. The study was approved by the Ethical Committee for Human Experimentation of the University of Geneva and was conducted in accordance with its rules and regulations.

Experimental design
Each subject spent 24 h in our respiratory chamber on 3 separate occasions and was randomly assigned to receive 1 of the following 3 treatments orally (in capsular form) 3 time/d (ie, 2 capsules with breakfast, lunch, and dinner): 1) a green tea extract containing 50 mg caffeine and 90 mg epigallocatechin gallate, 2) 50 mg caffeine, or 3) a placebo that consisted of cellulose as inert filler. The dosages represented the amount of caffeine and epigallocatechin gallate (the quantitatively most important catechin polyphenol) in 2 capsules. The green tea extract (code name: AR25) was obtained by alcohol extraction from dry tea leaves of unfermented Camellia sinensis, standardized at 25% catechins, and commercially prepared in capsular form under the name Exolise (Arkopharma Laboratories, Nice, France). Note that apart from (-)-epigallocatechin gallate, the green tea extract also contains substantial amounts of other catechins: (-)-epigallocatechin, (-)-epicatechin, and (-)-epicatechin gallate. (-)-Epigallocatechin gallate constitutes 50% of the total amount of tea catechins and is believed to be the most pharmacologically active tea catechin (14). In the present study, (-)-epigallocatechin gallate was found to constitute 72% of total catechins, such that the amount of total catechins consumed with each meal was 125 mg. Consequently, ingestion of capsules containing the green tea extract AR25 provided daily a total of 150 mg caffeine and 375 mg catechins, of which 270 mg was epigallocatechin gallate. The various treatments in the respiratory chamber were administered in a double-blind design and with a 5–10-d interval between successive 24-h trials for each subject. During the entire study period (lasting 5–6 wk), the subjects were prescribed a weight-maintenance diet consisting of 13% of energy as protein, 40% as fat, and 47% as carbohydrates. During each respiratory chamber trial, this diet was considered the "basal diet," which was fed at an energy level of 1.4 times the estimated basal energy requirements of the subject, predicted from the regression equation of Cunningham (15). Thus, during each of the subject's 3 respiratory chamber trials, the following conditions were the same: energy intake, nutrient composition of the diet, sedentary lifestyle pattern (reading, listening to radio, watching television, etc), pattern of physical activity, meal pattern, and time period for sleeping. No methylxanthine-containing foods or beverages were consumed 24 h before or during the stay in the respiratory chamber. During the first 8 h of each trial, the heart rate was monitored with a portable frequency meter.

Determination of daily energy expenditure and substrate oxidation
EE was continuously monitored by indirect calorimetry during the stay in the respiratory chamber, the details of which were described previously (16). The respiratory chamber had a large window overlooking the streets and was large enough (3 m long x 2.5 m wide x 2.5 m high) to provide the comforts of a hotel. It was furnished with a bed, resting armchair, table, wash basin and water tap, dry toilet, audiovisual equipment (television, video cassette recorder, radio, and tape recorder), intercom, and a telephone. The door was fitted with a double window as well as an air-lock system through which food and other items were provided. Complete privacy was obtainable by pulling a curtain over the windows. The chamber was sufficiently airtight to ensure that air left only through the apparatus that measures its flow rate and gas concentrations. A pump removed air continuously from the chamber at a rate that could be varied from between 50 and 100 L/min, which passed through a mass flow meter for continuous measurement of the flow rate. The effect of pumping air out resulted in air entering the chamber through a special inlet placed in the wall opposite the location where the air left. A fan ensured that the air was mixed inside the chamber and a thermostat ensured the maintenance of a constant and comfortable temperature. Air samples entering and leaving the chamber passed through differential analyzers for continuous measurements of differences in oxygen and carbon dioxide contents between extracted air and inlet air. These data were continuously fed into an online computerized data acquisition system, from which EE and the respiratory quotient (RQ) were calculated throughout the measurement periods. Measurements were accurate within 1–2%, as described previously (16). The oxidation rates of protein, carbohydrate, and fat were calculated from 24-h EE, RQ, and urinary nitrogen excretion for each 24-h stay in the respiratory chamber (17).

Measurement of urinary nitrogen and catecholamines
During each subject's stay in the respirometer, urine was collected into 2 or more 2-L opaque glass containers (containing 10 mL of 5 mol HCl/L each) over 2 periods to reflect diurnal and nocturnal phases, with the time intervals indicated below. After the 24-h collection period was complete, all urine samples were stored at -20°C until assayed for nitrogen with an autoanalyzer by the method of Kjeldahl and for epinephrine, norepinephrine, and dopamine concentrations by liquid chromatography with electrochemical detection.

Data presentation
EE, RQ, substrate oxidation, and urinary catecholamine data are reported as diurnal (corresponding to the first 15 h in the respiratory chamber, from 0800 to 2300), nocturnal (from 2300 to 0800 the next morning), and total 24-h values.

Statistics
Repeated-measures analysis of variance was used to determine significance. When statistically significant differences were detected, a post hoc pairwise comparison across treatments was performed by using Tukey's test. Significance was set at a P value < 0.05. The statistical analyses were performed by using the computer software program STATISTIK 4.0 (Analytic Software, St Paul).

	RESULTS

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Energy expenditure
Mean (±SEM) diurnal, nocturnal, and total 24-h EE values are presented in Table 1. Significant differences across treatments were observed only for diurnal and total 24-h EE. Diurnal EE was higher during treatment with the green tea extract than during treatment with placebo or caffeine, by 4.5% and 3.2%, respectively, but significantly so only for the green tea extract. Total 24-h EE with the green tea extract, however, was significantly higher than that with both the placebo and caffeine, by 3.5% and 2.8%, respectively. There were no significant differences in diurnal, nocturnal, or total 24-h EE between the caffeine and placebo groups. Individual changes (relative to placebo) in total 24-h EE indicated an increase in only 2 subjects after caffeine treatment, but an increase in 6 of the 10 subjects after treatment with the green tea extract, ranging from 266 to 836 kJ (mean or median of 330 kJ). No correlation was observed between the magnitude of thermogenic response and the degree of fatness (BMI or percentage of body fat) of the subjects.

	DISCUSSION

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Although both coffee and tea are widely consumed worldwide, our knowledge of their influence on energy metabolism has been limited to studies of coffee or to its main pharmacologically active ingredient caffeine. Therefore, the results of the present investigation are the first to show in humans that tea (albeit green tea) also has the potential to influence EE and substrate utilization. Because dietary energy intake and diet composition were identical during all treatments and because the subjects maintained the same feeding and physical activity patterns during each 24-h respiratory chamber trial, the 4% increase in 24-h EE during treatment with the green tea extract essentially reflects its stimulatory effect on thermogenesis. Furthermore, despite the absence of differences in urinary nitrogen excretion, and hence in protein oxidation rates, the observed reductions in RQ during treatment with the green tea extract suggest that fat oxidation was higher and carbohydrate oxidation was lower during this period than during the placebo period. Indeed, calculations of the relative contribution of substrate oxidation to daily EE indicated that the contribution of fat oxidation to 24-h EE, which was 31.6% with the placebo, was higher (41.5%) with the green tea extract. Of particular interest in this study was that the effects of the green tea extract in enhancing thermogenesis and fat oxidation could not be explained solely on the basis of its caffeine content because treatment with an amount of caffeine equivalent to that in the extract failed to alter EE, RQ, or substrate oxidation. The implication of this finding is that these metabolic effects resulted from ingredients other than caffeine in the green tea extract. The most likely explanation for the lack of a thermogenic effect of caffeine is that the dosage (50 mg 3 times/d) was below the threshold for stimulating thermogenesis. On the basis of data from the literature, a single oral dose of 100 mg caffeine is required to produce a thermogenic response sustainable for 1–2 h, and a stimulatory effect of caffeine per se on 24-h EE under respiratory chamber conditions has only been reported with dosages of 600–1000 mg caffeine/d (18, 19). It is therefore not surprising that in the present study, the administration of caffeine alone (<100 mg with each meal) failed to increase daily EE. Nonetheless, the amount of caffeine consumed during treatment with the green tea extract may have reached the critical dose, which, although ineffective by itself, may have enabled a synergistic interaction with other bioactive ingredients in the green tea extract to promote catecholamine-induced thermogenesis and fat oxidation.

Mechanism of action
Green tea is well known for being particularly rich in flavonoids (14), and several of these polyphenols—particularly the subclass of flavonoids commonly known as tea catechins—have been shown in vitro to inhibit COMT (11), the enzyme that degrades norepinephrine. Given the important role of the SNS and its neurotransmitter norepinephrine in the control of thermogenesis and fat oxidation, it is conceivable that these catechins, by inhibiting COMT, result in an increase in or a more prolonged effect of norepinephrine on thermogenesis and fat metabolism or both. Support for this contention comes from our previously reported in vitro studies on the respiration rate of brown adipose tissue, which indicated that 1) a green tea extract (rich in catechin polyphenols and to a lesser extent in caffeine) was more potent than were equimolar concentrations of caffeine alone in stimulating the respiration rate of brown adipose tissue (12), 2) the thermogenic effect of a green tea extract was markedly potentiated by enhancing the release of norepinephrine from the sympathetic nerve terminals with the use of ephedrine (12), and 3) the thermogenic effect of a green tea extract could be mimicked by epigallocatechin gallate (20). Furthermore, the assay of urinary catecholamines in the present study of humans showed a tendency for urinary norepinephrine (and its precursor dopamine), but not for epinephrine, to be higher in most subjects during treatment with the green tea extract; however, differences across treatments were only significant for total 24-h norepinephrine excretion. This observation is consistent with the inhibiting effect of green tea on COMT, the consequential reduction in norepinephrine degradation, and hence, the spillover of norepinephrine into the circulation, thereby accounting for the higher urinary excretion of norepinephrine. Such effects, resulting in a prolonged life of norepinephrine in the sympathetic synaptic cleft, could explain the observed effects of the extract in stimulating thermogenesis and fat oxidation.

It can be argued, however, that other tea flavonoids—such as quercetin and myricetin, which have also been shown to inhibit COMT in vitro (11)—may also have played a role in the metabolic effects of the green extract observed in the present study. However, there are only minute amounts of these flavonoids in green tea and their absorption when taken orally is doubtful, particularly because of evidence that flavonoids in food cannot generally be absorbed from the small intestine because they are bound to sugars as glycosides. By contrast, catechins are not only present in large quantities in green tea, but they are known to be better absorbed than are flavonoids. Indeed, substantial amounts of epigallocatechin gallate, epigallocatechin, and epicatechin have been measured in the plasma of human volunteers after ingestion of green tea powder, with peak plasma concentrations of catechins (nonconjugated) after 3 h of 3–3% of the ingested dose (21, 22). It is not known whether the relatively low ratios of circulating catechins to ingested catechins can be attributed to an efficient metabolism or to uptake by other tissues. However, the tissue concentrations of at least one of these tea catechins must have been high enough in our study to exert biological effects, as indicated by the stimulatory effect of the green tea extract on energy metabolism. Taken together, the results of these in vitro studies of rat brown adipose tissue thermogenesis (12) and in vivo studies of tea catechin bioavailability in humans (21, 22) suggest that the thermogenic effects of the green tea extract result, at least in part, from interactions between tea catechins, caffeine, and norepinephrine. The proposed mechanism is as follows: the catechins, by inhibiting COMT (and hence prolonging the life of norepinephrine in the synaptic cleft), and caffeine, by inhibiting phosphodiesterases (and hence prolonging the life of cAMP in the cell), result in an increase and more sustained effect of norepinephrine on thermogenesis.

Implications for weight control
First, the effect of the green tea extract on the metabolic rate represents an increase in 24-h EE of 4%. It is likely that a major component of this increase in daily EE was due to a cumulative increase in postprandial thermogenesis during consumption of the 3 meals in the diurnal period, particularly because no significant differences in nocturnal EE were observed. If, as generally accepted, thermogenesis contributes 8–10% of daily EE in a typical sedentary man (760–950 kJ in our subjects), this 4% increase in 24-h EE (328 kJ) due to the green tea extract would extrapolate to a 35–43% increase in the thermogenesis compartment of daily EE. This thermogenic effect of the extract (an increase of 328 kJ/d) was comparable with increases in daily EE seen in previous studies with much higher doses of caffeine in postobese and lean subjects (increases of 400 kJ) (18); however, only half of the thermogenic stimulation was the result of a combination of ephedrine and caffeine (800 kJ) (23). The results of these studies together with the results of our in vitro studies in brown adipose tissue—which indicate that the stimulatory effect of the extract on tissue thermogenesis was markedly potentiated in the presence of ephedrine (12, 20)—raise the possibility that the effect of the green tea extract could be greater under conditions of elevated sympathetic tone and norepinephrine release (ie, higher activity of COMT), such as during concomitant treatment with drugs that enhance norepinephrine release or when activity levels are higher than those under the confined and sedentary conditions of a respiratory chamber. Second, the differences in substrate utilization in favor of fat oxidation (lower RQ) in response to the green tea extract were much more consistent than were the differences in EE because lower RQs with the extract than with the placebo were observed in most of the subjects, including in those subjects who did not show a higher EE. This finding with the green tea extract is even more remarkable when compared with data indicating that caffeine ingestion alone, even at doses as high as 1000 mg/d, had no significant effect on the RQ during the diurnal or nocturnal period (19). Third, stimulation of thermogenesis and fat oxidation by the green tea extract was not accompanied by an increase in heart rate. In this respect, the green tea extract is distinct from sympathomimetic drugs, whose use as antiobesity thermogenic agents is limited by their adverse cardiovascular effects and, hence, are particularly inappropriate for obese individuals with hypertension and other cardiovascular complications.

Conclusion
In conclusion, oral administration of the green tea extract stimulated thermogenesis and fat oxidation and thus has the potential to influence body weight and body composition via changes in both EE and substrate utilization.

	REFERENCES

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 

1. Landsberg L, Young JB. Sympathoadrenal activity and obesity: physiological rationale for the use of adrenergic thermogenic drugs. Int J Obes Relat Metab Disord 1993;65:S29–34.
2. Dulloo AG. Strategies to counteract readjustments towards lower metabolic rates during obesity management. Nutrition 1993;9:366–72.[Medline]
3. Arch JRS, Wilson S. Prospects for ß₃-adrenoceptor agonists in the treatment of obesity and diabetes. Int J Obes Relat Metab Disord 1996;20:191–9.[Medline]
4. Dulloo AG. Spicing fat for combustion. Br J Nutr 1998;80:493–4.[Medline]
5. Henry CJK, Emery B. Effects of spiced food on metabolic rate. Hum Nutr Clin Nutr 1986;40C:165–8.[Medline]
6. Yoshioka M, St-Pierre S, Suzuki M, Tremblay A. Effects of red pepper added to high-fat and high-carbohydrate meals on energy metabolism and substrate utilization in Japanese women. Br J Nutr 1998;80:503–10.[Medline]
7. Dulloo AG. Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis. Int J Obes Relat Metab Disord 1993;17:S35–40.
8. Toubro S, Astrup A, Breum L, Quaade F. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. Int J Obes Relat Metab Disord 1993;17:S69–72.
9. Dulloo AG, Seydoux J, Girardier L. Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition? Metabolism 1992;41:1233–41.[Medline]
10. Durand J, Giacobino JP, Girardier L. Catechol-O-methyl-transferase activity in whole brown adipose tissue of rat in vitro. In: Girardier L, Seydoux J, eds. Effectors of thermogenesis. Basel, Switzerland: Birkhauser, 1977:45–53.
11. Borchardt RT, Huber JA. Catechol-O-methyltransferase: structure-activity relationships for inhibition by flavonoids. J Med Chem 1975;18:120–2.[Medline]
12. Dulloo AG, Seydoux J, Girardier L. Tealine and thermogenesis: interactions between polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord 1996;20(suppl):71(abstr).
13. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness measurements of 481 men and women aged 16–72 years. Br J Nutr 1974;32:77–97.[Medline]
14. Stagg GV, Millin DJ. The nutritional and therapeutic value of tea—a review. J Sci Food Agric 1975;26:1439–59.
15. Cunningham JJ. Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation. Am J Clin Nutr 1991;54:963–9.[Abstract/Free Full Text]
16. Dulloo AG, Fathi M, Mensi N, Girardier L. Twenty-four hour energy expenditure and urinary catecholamines of humans consuming low-to-moderate amounts of medium-chain-triglycerides: a dose-response study in a respiratory chamber. Eur J Clin Nutr 1996;50:152–8.[Medline]
17. Jequier E, Acheson KJ, Schutz Y. Assessment of energy expenditure and fuel utilization in man. Annu Rev Nutr 1987;7:187–208.[Medline]
18. Dulloo AG, Geissler CA, Horton T, Collins A, Miller DS. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and post-obese human volunteers. Am J Clin Nutr 1989;49:44–50.[Abstract/Free Full Text]
19. Bracco D, Ferrarra JM, Arnaud MJ, Jéquier E, Schutz Y. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol 1995;269:E671–8.[Abstract/Free Full Text]
20. Dulloo AG, Seydoux J, Girardier L, Chantra P, Vandermander J. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord (in press).
21. Lee MJ, Wang ZY, Li H, et al. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 1995;44:393–9.
22. Hollman PCH, Tijburg LBM, Yang CS. Bioavailability of flavonoids from tea. Crit Rev Food Sci Nutr 1997;37:719–38.[Medline]
23. Dulloo AG, Miller DS. The thermogenic properties of ephedrine/ methylxanthine mixtures: human studies. Int J Obes 1986;10:467–81.[Medline]

This article has been cited by other articles:

				L. A. Hughes, I. C. Arts, T. Ambergen, H. A. Brants, P. C Dagnelie, R A. Goldbohm, P. A van den Brandt, and M. P Weijenberg Higher dietary flavone, flavonol, and catechin intakes are associated with less of an increase in BMI over time in women: a longitudinal analysis from the Netherlands Cohort Study Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1341 - 1352. [Abstract] [Full Text] [PDF]

				R. Monteiro, M. Assuncao, J. P. Andrade, D. Neves, C. Calhau, and I. Azevedo Chronic Green Tea Consumption Decreases Body Mass, Induces Aromatase Expression, and Changes Proliferation and Apoptosis in Adult Male Rat Adipose Tissue J. Nutr., November 1, 2008; 138(11): 2156 - 2163. [Abstract] [Full Text] [PDF]

				S. Egert, S. Wolffram, A. Bosy-Westphal, C. Boesch-Saadatmandi, A. E. Wagner, J. Frank, G. Rimbach, and M. J. Mueller Daily Quercetin Supplementation Dose-Dependently Increases Plasma Quercetin Concentrations in Healthy Humans J. Nutr., September 1, 2008; 138(9): 1615 - 1621. [Abstract] [Full Text] [PDF]

				M. Bose, J. D. Lambert, J. Ju, K. R. Reuhl, S. A. Shapses, and C. S. Yang The Major Green Tea Polyphenol, (-)-Epigallocatechin-3-Gallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat-Fed Mice J. Nutr., September 1, 2008; 138(9): 1677 - 1683. [Abstract] [Full Text] [PDF]

				S. Kuriyama The Relation between Green Tea Consumption and Cardiovascular Disease as Evidenced by Epidemiological Studies J. Nutr., August 1, 2008; 138(8): 1548S - 1553S. [Abstract] [Full Text] [PDF]

				M. C Venables, C. J Hulston, H. R Cox, and A. E Jeukendrup Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans Am. J. Clinical Nutrition, March 1, 2008; 87(3): 778 - 784. [Abstract] [Full Text] [PDF]

				Q. F. Collins, H.-Y. Liu, J. Pi, Z. Liu, M. J. Quon, and W. Cao Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5'-AMP-activated Protein Kinase J. Biol. Chem., October 12, 2007; 282(41): 30143 - 30149. [Abstract] [Full Text] [PDF]

				S. Wolfram Effects of Green Tea and EGCG on Cardiovascular and Metabolic Health J. Am. Coll. Nutr., August 1, 2007; 26(4): 373S - 388S. [Abstract] [Full Text] [PDF]

				M. Boschmann and F. Thielecke The Effects of Epigallocatechin-3-Gallate on Thermogenesis and Fat Oxidation in Obese Men: A Pilot Study J. Am. Coll. Nutr., August 1, 2007; 26(4): 389S - 395S. [Abstract] [Full Text] [PDF]

				A. M. Hill, A. M. Coates, J. D. Buckley, R. Ross, F. Thielecke, and P. R.C. Howe Can EGCG Reduce Abdominal Fat in Obese Subjects? J. Am. Coll. Nutr., August 1, 2007; 26(4): 396S - 402S. [Abstract] [Full Text] [PDF]

				G. A. Bray and F. L. Greenway Pharmacological Treatment of the Overweight Patient Pharmacol. Rev., June 1, 2007; 59(2): 151 - 184. [Full Text] [PDF]

				G. D Bolden The effect of teas on malabsorption of carbohydrates Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1164 - 1164. [Full Text] [PDF]

				J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al. Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr., March 1, 2007; 137(3): 718S - 737S. [Abstract] [Full Text] [PDF]

				K. Diepvens, K. R. Westerterp, and M. S. Westerterp-Plantenga Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R77 - R85. [Abstract] [Full Text] [PDF]

				K. J. Mukamal, M. Alert, M. Maclure, J. E. Muller, and M. A. Mittleman Tea Consumption and Infarct-Related Ventricular Arrhythmias: The Determinants of Myocardial Infarction Onset Study J. Am. Coll. Nutr., December 1, 2006; 25(6): 472 - 479. [Abstract] [Full Text] [PDF]

				J. A Greenberg, C. N Boozer, and A. Geliebter Coffee, diabetes, and weight control. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 682 - 693. [Abstract] [Full Text] [PDF]

				S. Wolfram, D. Raederstorff, M. Preller, Y. Wang, S. R. Teixeira, C. Riegger, and P. Weber Epigallocatechin Gallate Supplementation Alleviates Diabetes in Rodents J. Nutr., October 1, 2006; 136(10): 2512 - 2518. [Abstract] [Full Text] [PDF]

				L. Zhong, J. K Furne, and M. D Levitt An extract of black, green, and mulberry teas causes malabsorption of carbohydrate but not of triacylglycerol in healthy volunteers. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 551 - 555. [Abstract] [Full Text] [PDF]

				S. Gruendel, A. L. Garcia, B. Otto, C. Mueller, J. Steiniger, M. O. Weickert, M. Speth, N. Katz, and C. Koebnick Carob Pulp Preparation Rich in Insoluble Dietary Fiber and Polyphenols Enhances Lipid Oxidation and Lowers Postprandial Acylated Ghrelin in Humans J. Nutr., June 1, 2006; 136(6): 1533 - 1538. [Abstract] [Full Text] [PDF]

				T. Murase, S. Haramizu, A. Shimotoyodome, I. Tokimitsu, and T. Hase Green tea extract improves running endurance in mice by stimulating lipid utilization during exercise Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1550 - R1556. [Abstract] [Full Text] [PDF]

				C. Cabrera, R. Artacho, and R. Gimenez Beneficial effects of green tea--a review. J. Am. Coll. Nutr., April 1, 2006; 25(2): 79 - 99. [Abstract] [Full Text] [PDF]

				H.-S. Liu, Y.-H. Chen, P.-F. Hung, and Y.-H. Kao Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E273 - E281. [Abstract] [Full Text] [PDF]

				C. C.W. Chan, M. W.L. Koo, E. H.Y. Ng, O.-S. Tang, W. S.B. Yeung, and P.-C. Ho Effects of Chinese Green Tea on Weight, and Hormonal and Biochemical Profiles in Obese Patients With Polycystic Ovary Syndrome--A Randomized Placebo-Controlled Trial Reproductive Sciences, January 1, 2006; 13(1): 63 - 68. [Abstract] [PDF]

				P.-F. Hung, B.-T. Wu, H.-C. Chen, Y.-H. Chen, C.-L. Chen, M.-H. Wu, H.-C. Liu, M.-J. Lee, and Y.-H. Kao Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways Am J Physiol Cell Physiol, May 1, 2005; 288(5): C1094 - C1108. [Abstract] [Full Text] [PDF]

				T. Murase, S. Haramizu, A. Shimotoyodome, A. Nagasawa, and I. Tokimitsu Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R708 - R715. [Abstract] [Full Text] [PDF]

				M.-P. St-Onge Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? Am. J. Clinical Nutrition, January 1, 2005; 81(1): 7 - 15. [Abstract] [Full Text] [PDF]

				T. Nagao, Y. Komine, S. Soga, S. Meguro, T. Hase, Y. Tanaka, and I. Tokimitsu Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men Am. J. Clinical Nutrition, January 1, 2005; 81(1): 122 - 129. [Abstract] [Full Text] [PDF]

				G. Williamson and C. Manach Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 243S - 255S. [Abstract] [Full Text] [PDF]

				M. Tanaka, K. Itoh, S. Abe, K. Imai, T. Masuda, R. Koga, H. Itoh, Y. Konomi, N. Kinukawa, and T. Sakata Irregular Patterns in the Daily Weight Chart at Night Predict Body Weight Regain Experimental Biology and Medicine, October 1, 2004; 229(9): 940 - 945. [Abstract] [Full Text] [PDF]

				A. Fugh-Berman and A. Myers Citrus aurantium, an Ingredient of Dietary Supplements Marketed for Weight Loss: Current Status of Clinical and Basic Research Experimental Biology and Medicine, September 1, 2004; 229(8): 698 - 704. [Abstract] [Full Text] [PDF]